VRTX Historical Earnings image   This VRTX historical earnings page last updated 8/8/2022
VRTX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20222.20B
Q1 20225/5/20222.10B
Q4 20211/26/20222.07B
Q3 202111/2/20211.98B
Q2 20217/29/20211.79B
Q1 20214/29/20211.72B
Q4 20202/1/20211.63B
Q3 202010/29/20201.54B
Q2 20207/30/20201.52B
Q1 20204/29/20201.51B
Q4 20191/30/20201.26B
Q3 201910/30/20190.95B
Q2 20197/31/20190.94B
Q1 20194/30/20190.86B
Q4 20182/5/20190.87B
Q3 201810/24/20180.78B
Q2 20187/25/20180.75B
Q1 20184/26/20180.64B
Q4 20171/31/20180.62B
Q3 201710/25/20170.55B
Q2 20177/26/20170.52B
Q1 20174/27/20170.48B
Q4 20161/25/20170.46B
Q3 201610/25/20160.41B
Q2 20167/27/20160.43B
Q1 20164/27/20160.40B
Q4 20151/27/20160.41B
Q3 201510/28/20150.30B
Q2 20157/29/20150.16B
Q1 20154/29/20150.14B
Q4 20141/28/20150.14B
Q3 201410/28/20140.18B
Q2 20147/29/20140.14B
Q1 20145/1/20140.12B
Q4 20131/29/20140.35B
Q3 201310/29/20130.22B
Q2 20137/29/20130.31B
Q1 20134/30/20130.33B
Q4 20121/29/20130.33B
Q3 201211/1/20120.34B
Q2 20127/30/20120.42B
Q1 20124/26/20120.44B
VRTX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/4/20223.600
Q1 20225/5/20223.520
Q4 20211/26/20223.370
Q3 202111/2/20213.560
Q2 20217/29/20213.110
Q1 20214/29/20212.980
Q4 20202/1/20212.510
Q3 202010/29/20202.640
Q2 20207/30/20202.610
Q1 20204/29/20202.560
Q4 20191/30/20201.700
Q3 201910/30/20191.230
Q2 20197/31/20191.260
Q1 20194/30/20191.140
Q4 20182/5/20191.3
Q3 201810/24/20181.09
Q2 20187/25/20180.94
Q1 20184/26/20180.76
Q4 20171/31/20180.61
Q3 201710/25/20170.53
Q2 20177/26/20170.39
Q1 20174/27/20170.41
Q4 20161/25/20170.35
Q3 201610/25/20160.16
Q2 20167/27/20160.24
Q1 20164/27/20160.09
Q4 20151/27/20160.17
Q3 201510/28/2015-0.13
Q2 20157/29/2015-0.54
Q1 20154/29/2015-0.62
Q4 20141/28/2015-0.55
Q3 201410/28/2014-0.37
Q2 20147/29/2014-0.68
Q1 20145/1/2014-1
Q4 20131/29/20140.19
Q3 201310/29/2013-0.32
Q2 20137/29/2013-0.03
Q1 20134/30/20130.03
Q4 20121/29/20130.04
Q3 201211/1/2012-0.27
Q2 20127/30/20120.46
Q1 20124/26/20120.550
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VSTM Historical Earnings
VTGN Historical Earnings
VTRS Historical Earnings
VTVT Historical Earnings
VVOS Historical Earnings
VXRT Historical Earnings
VYGR Historical Earnings
VYNE Historical Earnings
VYNT Historical Earnings
WAT Historical Earnings
What was the record high VRTX historical earnings result?
In terms of earnings or revenue, what is the best VRTX historical earnings result that Vertex Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest VRTX historical earnings result was set in Q2 2022, when Vertex Pharmaceuticals posted results of 3.600/share. The most successful revenue quarter within our data set was Q2 2022 when Vertex Pharmaceuticals reported revenue of 2.20B.

What was the lowest Vertex Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest VRTX has reported, and when?

✔️Accepted answer: Within our data set, the lowest VRTX historical earnings result was set in Q1 2014, when Vertex Pharmaceuticals posted results of -1/share. The smallest revenue quarter within our data set was Q1 2014 when Vertex Pharmaceuticals reported revenue of 0.12B.

On this page we presented the VRTX historical earnings date information for Vertex Pharmaceuticals. Reviewing that VRTX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2022, when VRTX posted adjusted EPS of 3.600/share. Meanwhile the lowest VRTX historical earnings result was in Q1 2014, when VRTX posted adjusted EPS of -1/share. Moving to Vertex Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when VRTX reported 2.20B in revenue, while the smallest revenue quarter was Q1 2014 when VRTX reported 0.12B in revenue.

For self directed investors doing their due diligence on VRTX or any other given stock, their research can benefit from looking into all of the Vertex Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Vertex Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for VRTX. Thanks for visiting, and the next time you need to research VRTX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: FWM Options Chain, Funds Holding INM, ALPN Stock Predictions.

 

VRTX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.